254 related articles for article (PubMed ID: 9269768)
1. Human kininogens regulate thrombin binding to platelets through the glycoprotein Ib-IX-V complex.
Bradford HN; Dela Cadena RA; Kunapuli SP; Dong JF; Löpez JA; Colman RW
Blood; 1997 Aug; 90(4):1508-15. PubMed ID: 9269768
[TBL] [Abstract][Full Text] [Related]
2. Human factor XII binding to the glycoprotein Ib-IX-V complex inhibits thrombin-induced platelet aggregation.
Bradford HN; Pixley RA; Colman RW
J Biol Chem; 2000 Jul; 275(30):22756-63. PubMed ID: 10801853
[TBL] [Abstract][Full Text] [Related]
3. RETRACTED: Factor XI binding to the platelet glycoprotein Ib-IX-V complex promotes factor XI activation by thrombin.
Baglia FA; Badellino KO; Li CQ; Lopez JA; Walsh PN
J Biol Chem; 2002 Jan; 277(3):1662-8. PubMed ID: 11696542
[TBL] [Abstract][Full Text] [Related]
4. Role of glycoprotein V in the formation of the platelet high-affinity thrombin-binding site.
Dong JF; Sae-Tung G; López JA
Blood; 1997 Jun; 89(12):4355-63. PubMed ID: 9192758
[TBL] [Abstract][Full Text] [Related]
5. Binding of purified 14-3-3 zeta signaling protein to discrete amino acid sequences within the cytoplasmic domain of the platelet membrane glycoprotein Ib-IX-V complex.
Andrews RK; Harris SJ; McNally T; Berndt MC
Biochemistry; 1998 Jan; 37(2):638-47. PubMed ID: 9425086
[TBL] [Abstract][Full Text] [Related]
6. Thrombin-induced platelet aggregation is inhibited by the heptapeptide Leu271-Ala277 of domain 3 in the heavy chain of high molecular weight kininogen.
Kunapuli SP; Bradford HN; Jameson BA; DeLa Cadena RA; Rick L; Wassell RP; Colman RW
J Biol Chem; 1996 May; 271(19):11228-35. PubMed ID: 8626672
[TBL] [Abstract][Full Text] [Related]
7. Phosphoinositide 3-kinase forms a complex with platelet membrane glycoprotein Ib-IX-V complex and 14-3-3zeta.
Munday AD; Berndt MC; Mitchell CA
Blood; 2000 Jul; 96(2):577-84. PubMed ID: 10887121
[TBL] [Abstract][Full Text] [Related]
8. Binding of a novel 50-kilodalton alboaggregin from Trimeresurus albolabris and related viper venom proteins to the platelet membrane glycoprotein Ib-IX-V complex. Effect on platelet aggregation and glycoprotein Ib-mediated platelet activation.
Andrews RK; Kroll MH; Ward CM; Rose JW; Scarborough RM; Smith AI; López JA; Berndt MC
Biochemistry; 1996 Sep; 35(38):12629-39. PubMed ID: 8823201
[TBL] [Abstract][Full Text] [Related]
9. High molecular weight kininogen inhibits thrombin-induced platelet aggregation and cleavage of aggregin by inhibiting binding of thrombin to platelets.
Puri RN; Zhou F; Hu CJ; Colman RF; Colman RW
Blood; 1991 Feb; 77(3):500-7. PubMed ID: 1846761
[TBL] [Abstract][Full Text] [Related]
10. A thrombin receptor function for platelet glycoprotein Ib-IX unmasked by cleavage of glycoprotein V.
Ramakrishnan V; DeGuzman F; Bao M; Hall SW; Leung LL; Phillips DR
Proc Natl Acad Sci U S A; 2001 Feb; 98(4):1823-8. PubMed ID: 11172035
[TBL] [Abstract][Full Text] [Related]
11. Structure and function of the von Willebrand factor A1 domain: analysis with monoclonal antibodies reveals distinct binding sites involved in recognition of the platelet membrane glycoprotein Ib-IX-V complex and ristocetin-dependent activation.
De Luca M; Facey DA; Favaloro EJ; Hertzberg MS; Whisstock JC; McNally T; Andrews RK; Berndt MC
Blood; 2000 Jan; 95(1):164-72. PubMed ID: 10607699
[TBL] [Abstract][Full Text] [Related]
12. Variant Bernard-Soulier syndrome type bolzano. A congenital bleeding disorder due to a structural and functional abnormality of the platelet glycoprotein Ib-IX complex.
De Marco L; Mazzucato M; Fabris F; De Roia D; Coser P; Girolami A; Vicente V; Ruggeri ZM
J Clin Invest; 1990 Jul; 86(1):25-31. PubMed ID: 1694864
[TBL] [Abstract][Full Text] [Related]
13. Cytoskeletal regulation of the platelet glycoprotein Ib/V/IX-von willebrand factor interaction.
Mistry N; Cranmer SL; Yuan Y; Mangin P; Dopheide SM; Harper I; Giuliano S; Dunstan DE; Lanza F; Salem HH; Jackson SP
Blood; 2000 Nov; 96(10):3480-9. PubMed ID: 11071645
[TBL] [Abstract][Full Text] [Related]
14. Unique pathway of thrombin-induced platelet aggregation mediated by glycoprotein Ib.
Soslau G; Class R; Morgan DA; Foster C; Lord ST; Marchese P; Ruggeri ZM
J Biol Chem; 2001 Jun; 276(24):21173-83. PubMed ID: 11283012
[TBL] [Abstract][Full Text] [Related]
15. Conformational changes in the A3 domain of von Willebrand factor modulate the interaction of the A1 domain with platelet glycoprotein Ib.
Obert B; Houllier A; Meyer D; Girma JP
Blood; 1999 Mar; 93(6):1959-68. PubMed ID: 10068669
[TBL] [Abstract][Full Text] [Related]
16. A dinucleotide deletion results in defective membrane anchoring and circulating soluble glycoprotein Ib alpha in a novel form of Bernard-Soulier syndrome.
Kenny D; Newman PJ; Morateck PA; Montgomery RR
Blood; 1997 Oct; 90(7):2626-33. PubMed ID: 9326229
[TBL] [Abstract][Full Text] [Related]
17. Modulation of thrombin-induced platelet aggregation by inhibition of calpain by a synthetic peptide derived from the thiol-protease inhibitory sequence of kininogens and S-(3-nitro-2-pyridinesulfenyl)-cysteine.
Puri RN; Matsueda R; Umeyama H; Bradford HN; Colman RW
Eur J Biochem; 1993 May; 214(1):233-41. PubMed ID: 8389701
[TBL] [Abstract][Full Text] [Related]
18. Thrombin-induced platelet activation is inhibited by high- and low-molecular-weight heparin.
De Candia E; De Cristofaro R; Landolfi R
Circulation; 1999 Jun; 99(25):3308-14. PubMed ID: 10385507
[TBL] [Abstract][Full Text] [Related]
19. Factor XI interacts with the leucine-rich repeats of glycoprotein Ibalpha on the activated platelet.
Baglia FA; Shrimpton CN; Emsley J; Kitagawa K; Ruggeri ZM; López JA; Walsh PN
J Biol Chem; 2004 Nov; 279(47):49323-9. PubMed ID: 15375170
[TBL] [Abstract][Full Text] [Related]
20. Low molecular weight kininogen binds to platelets to modulate thrombin-induced platelet activation.
Meloni FJ; Schmaier AH
J Biol Chem; 1991 Apr; 266(11):6786-94. PubMed ID: 2016293
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
